Acasti Pharma (NASDAQ:ACST) Lowered to “Hold” at Zacks Investment Research – TechNewsObserver
Acasti Pharma (NASDAQ:ACST) Lowered to “Hold” at Zacks Investment Research TechNewsObserver
Zacks Investment Research lowered shares of Acasti Pharma (NASDAQ:ACST) from a buy rating to a hold rating in a report published on Tuesday, Zacks.com …
Source: Investment New Feed